Evidence-Based Drug Policy Act of 2025 repeals section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998.
The Evidence-Based Drug Policy Act of 2025 repeals section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. This section previously required the Office of National Drug Control Policy to prioritize funding for drug demand reduction programs based on scientific evidence. The bill aims to remove this requirement, potentially affecting how drug demand reduction programs are funded and prioritized.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.